Manager, Commercial Execution Operations, CNE
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Revolution Medicines is establishing its European headquarters and expanding its presence across the CNE (Central, Northern, Eastern Europe) region. The Manager Commercial Execution Ops CNE Region role leads the execution of high-complexity, cross-functional initiatives that ensure operational readiness, governance, and alignment across the European region. Serving as an operational support to the VP, General Manager CNE Region, this individual drives the design and implementation of scala
